Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SK-1403 Long-term Treatment Study - Long-term Study in Patients With Secondary Hyperparathyroidism Receiving Hemodialysis -

NCT03626948 is registered in ClinicalTrials.gov with Sanwa Kagaku Kenkyusho Co., Ltd. as lead sponsor.

NCT NCT03626948
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03626948 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SK-1403 Long-term Treatment Study - Long-term Study in Patients With Secondary Hyperparathyroidism Receiving Hemodialysis -
Lead sponsor
Sanwa Kagaku Kenkyusho Co., Ltd.
Phase
Phase 3
Overall status
Completed
Start date
September 13, 2018
Completion date
February 5, 2020
Enrollment
157 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

secondary hyperparathyroidism